Position in PGEN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$817,127
-$37,783 QoQ
Shares Held
211,144
+3.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Sep 30, 2025CallValue
$32,900
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. PGEN ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in PGEN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $817,127 | 211,144 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $854,910 | 204,524 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $32,900 | 10,000 | Call | Sole | 2025-11-12 | |
| 2025-09-30 | $537,664 | 163,424 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,600 | 17,324 | Shares | Sole | 2025-08-12 | |
| 2025-06-30 | $21,300 | 15,000 | Call | Sole | 2025-08-12 | |
| 2025-03-31 | $26,471 | 17,766 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $42,136 | 37,622 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $61,723 | 64,972 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $220,286 | 139,422 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $222,573 | 153,499 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $55,608 | 41,499 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $59,177 | 41,674 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $49,609 | 43,139 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $44,826 | 42,289 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $47,987 | 31,571 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $69,050 | 32,571 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $43,645 | 32,571 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $69,722 | 33,044 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $124,448 | 33,544 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $186,596 | 37,394 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $294,664 | 45,194 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $309,664 | 44,944 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $508,011 | 49,805 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $140,199 | 40,057 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $185,273 | 37,129 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $116,337 | 34,217 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||